entry exit points

Here are the entry and exit points for CYCC (Cyclacel Pharmaceuticals): 1. **Entry Point**: The stock has experienced a significant increase from July 16 to July 17, with a high point of $14.00 on July 23, 2025. An entry point could be considered around $13.00 to $14.00, taking into account the recent volatility and the potential for further price appreciation. 2. **Exit Point**: A potential exit point could be set around $18.00, which is the resistance level as of July 23, 2025. This level could act as a ceiling for the stock price in the short term. Alternatively, if the stock continues to show strong momentum, investors may consider holding onto their position until higher price targets are achieved. |code|Ticker|Name|Date|Support Level|Resistance Level|market_code| |---|---|---|---|---|---|---| |CYCC|CYCC.O|Cyclacel|20250723|10.0518|18.0000|186| In terms of technical indicators, the MACD histogram has a positive divergence, which could suggest a short-term bullish movement. However, the RSI is at 70.5, which is considered to be in the overbought territory and may indicate a potential for a pullback or consolidation. |code|Ticker|Name|Date|Closing Price|market_code| |---|---|---|---|---|---| |CYCC|CYCC.O|Cyclacel|20250723|14|186| Overall, the entry and exit points should be based on a combination of technical analysis and market conditions, and investors should be prepared to adjust their strategies as needed based on new information or changes in the stock's momentum.